Advertisement
Expert Commentary

Expert Commentary In an Expert Commentary, authors discuss the clinical, policy, public-health, or research implications of a freely available research article.

See all article types »

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis

  • Sara Lustigman mail,

    slustigman@nybloodcenter.org

    Affiliation: Laboratory of Molecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America

    X
  • James P. McCarter

    Affiliations: Divergence Inc., St. Louis, Missouri, United States of America, Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Published: August 30, 2007
  • DOI: 10.1371/journal.pntd.0000076

About the Authors

Sara Lustigman
Laboratory of Molecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America
James P. McCarter
Divergence Inc., St. Louis, Missouri, United States of America
James P. McCarter
Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America

Corresponding Author

Email: slustigman@nybloodcenter.org

Competing Interests

SL has received research grants for the development of anti-Onchocerca vaccines and macrofilaricides. JPM is a share-holder and employee of Divergence, Inc., a company that works on parasite control in plants, animals, and humans.